Table 3 Clinical and epidemiological characteristics of patients with and without DM separated to cirrhosis and chronic hepatitis groups

Number

22

19

14

88

Sex

NS

NS

   Female

4 (18.2%)

3 (15.8%)

2 (14.3%)

12 (13.6%)

   Male

18 (81.8%)

16 (84.2%)

12 (85.7%)

76 (86.4%)

Age

56.9 ± 10.6

46.6 ± 10.0

0.003

49.7 ± 7.8

39.9 ± 10.7

0.001

CLD etiology

NS

NS

   HBV

11 (50.0%)

13 (68.4%)

10 (71.4%)

37 (42.0%)

   HCV

8 (36.4%)

4 (21.1%)

4 (28.6%)

51 (58.0%)

   Criptogenic

3 (13.6%)

2 (10.5%)

-

-

Family history of DM

NS

0.01

   Yes

9 (40.9%)

3 (15.8%)

8 (57.1%)

21 (23.9%)

   No

13 (59.1%)

16 (84.2%)

6 (42.9%)

67 (76.1%)

History of hypertension

NS

NS

   Yes

6 (27.3%)

1 (5.3%)

3 (21.4%)

8 (9.1%)

   No

16 (72.7%)

18 (94.7%)

11 (78.6%)

80 (90.9%)

BMI

26.4 ± 3.4

26.4 ± 4.0

NS

27.7 ± 4.8

24.5 ± 3.1

0.02

Interferon therapy

NS

NS

   Yes

2 (9.1%)

3 (15.8%)

4 (28.6%)

46 (52.3%)

   No

20 (90.9%)

16 (84.2%)

10 (71.4%)

42 (47.7%)

Smoking

NS

NS

   Yes

5 (22.7%)

5 (26.3%)

7 (50.0%)

25 (28.4%)

   No

17 (77.3%)

14 (73.7%)

7 (50.0%)

63 (71.6%)

TG

145.5 ± 58.6

109.3 ± 75.2

NS

174.9 ± 82.5

140.6 ± 53.8

NS

Chol

141.6 ± 50.5

151.8± 32.5

NS

199.8 ± 42.8

163.9 ± 36.1

NS

Child-Pugh's score

0.04

   Score A

13 (65.0%)

18 (94.7%)

-

-

-

   Score B

7 (35.0%)

1 (5.3%)

Histological staging*

0.003

   0–1

-

-

-

1 (8.3%)

33 (41.8%)

   2–3

3 (25.0%)

30 (38.0%)

   4–6

8 (66.7%)

16 (20.3%)

Histological grading*

NS

   0–4

-

-

-

2 (16.7%)

36 (45.6%)

   5–8

8 (66.7%)

34 (43.0%)

   ≥ 9

2 (16.7%)

9 (11.4%)